Mizuho Securities Upgrades DepoMed Inc (DEPO) to Buy

November 9, 2016 6:14 AM EST
Get Alerts DEPO Hot Sheet
Price: $20.20 +0.75%

Rating Summary:
    10 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade DEPO Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Mizuho Securities upgraded DepoMed Inc (NASDAQ: DEPO) from Neutral to Buy with a price target of $24.00 (from $27.00) following the sell-off, saying they believe a deal will happen.

Analyst Irina Koffler commented, "We upgrade DEPO to Buy after the large sell-off. We still think a deal process could be underway, and the wholesaler/rebate issues should not derail this event. However, we think DEPO could be somewhat devalued by a more negative outlook on future Nucynta discounts. We lower PT to $24 from $27 based on lower Nucynta and lower sales multiples in a potential deal."

For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.

Shares of DepoMed Inc closed at $19.01 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst PT Change, Rumors, Upgrades

Related Entities

Irina Koffler

Add Your Comment